Search Results
Viewing: 431-440 of 542 | All
News
Cure SMA Provides Additional Funding for Promising Spinal Muscular Atrophy Research at Nationwide Childrens Hospital
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
Article
Pediatric Bioethics
The Advanced Competency in Pediatric Bioethics for pediatric residents provides training, experience, and skills necessary to become a physician leader in improving the ethical care of children.
News
Ohio Pediatric Care Alliance Opens March 24, 2014
Officials at Dayton Children’s Hospital and Nationwide Children’s Hospital are pleased to announce their joint outpatient specialty care center will open March 24, 2014.
Condition
Spinal Muscular Atrophy
Spinal muscular atrophies (SMA) are a group of genetic (passed down by parents) diseases that affect motor neurons (nerve cells) in the spinal cord, causing the weakening of voluntary muscles (muscles that you control).
News
FDA Approves First Gene Therapy Treatment for SMA Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its approval of Zolgensma® for spinal muscular atrophy (SMA) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
Article
Publications and Presentations
Article
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a digital newsletter personalized for the pediatric provider to deliver up-to-date resources, research announcements and more.
Condition
Intracranial Hypertension (Pseudotumor Cerebri)
Idiopathic intracranial hypertension, sometimes called pseudotumor cerebri, is a condition in which the cerebro-spinal fluid is not able to drain normally.
Article
Wedemeyer Lab
The Wedemeyer Laboratory seeks to apply state of the art genomics technologies to better understand common neurosurgical disease processes in children and improve the overall neurosurgical care for the children in our community.
Article
Stottmann Lab
The long-term goals of the Stottmann Lab are to understand the genes and molecular mechanisms guiding normal development of both the brain and face.